161 related articles for article (PubMed ID: 19110646)
1. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.
Wilson CA; Cichutek K
Methods Mol Biol; 2009; 506():477-88. PubMed ID: 19110646
[TBL] [Abstract][Full Text] [Related]
2. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
3. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
4. Lentiviruses in gene therapy clinical research.
Connolly JB
Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene.
Li Z; Kustikova OS; Kamino K; Neumann T; Rhein M; Grassman E; Fehse B; Baum C
Ann N Y Acad Sci; 2007 Jun; 1106():95-113. PubMed ID: 17395733
[TBL] [Abstract][Full Text] [Related]
6. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
Dropulic B
Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
[TBL] [Abstract][Full Text] [Related]
7. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.
Miskin J; Chipchase D; Rohll J; Beard G; Wardell T; Angell D; Roehl H; Jolly D; Kingsman S; Mitrophanous K
Gene Ther; 2006 Feb; 13(3):196-205. PubMed ID: 16208418
[TBL] [Abstract][Full Text] [Related]
8. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
Kang EM; Tisdale JF
Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
[TBL] [Abstract][Full Text] [Related]
9. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
10. Copy number determination of genetically-modified hematopoietic stem cells.
Schuesler T; Reeves L; Kalle Cv; Grassman E
Methods Mol Biol; 2009; 506():281-98. PubMed ID: 19110633
[TBL] [Abstract][Full Text] [Related]
11. Murine hematopoietic stem cell transduction using retroviral vectors.
Modlich U; Schambach A; Li Z; Schiedlmeier B
Methods Mol Biol; 2009; 506():23-31. PubMed ID: 19110617
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
13. Retroviral vectors: new applications for an old tool.
Barquinero J; Eixarch H; Pérez-Melgosa M
Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
[TBL] [Abstract][Full Text] [Related]
14. Genetic modification of lymphocytes by retrovirus-based vectors.
Suerth JD; Schambach A; Baum C
Curr Opin Immunol; 2012 Oct; 24(5):598-608. PubMed ID: 22995202
[TBL] [Abstract][Full Text] [Related]
15. Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells.
Schambach A; Swaney WP; van der Loo JC
Methods Mol Biol; 2009; 506():191-205. PubMed ID: 19110628
[TBL] [Abstract][Full Text] [Related]
16. DNA transposons for modification of human primary T lymphocytes.
Huang X; Wilber A; McIvor RS; Zhou X
Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a retroviral vector for transduction of human CD34 positive cells.
Szyda A; Paprocka M; Krawczenko A; Lenart K; Heimrath J; Grabarczyk P; Mackiewicz A; Duś D
Acta Biochim Pol; 2006; 53(4):815-23. PubMed ID: 17160143
[TBL] [Abstract][Full Text] [Related]
18. In situ (in vivo) gene transfer into murine bone marrow stem cells.
Pan D
Methods Mol Biol; 2009; 506():159-69. PubMed ID: 19110626
[TBL] [Abstract][Full Text] [Related]
19. Retroviral vector production in the National Gene Vector Laboratory at Indiana University.
Cornetta K; Matheson L; Ballas C
Gene Ther; 2005 Oct; 12 Suppl 1():S28-35. PubMed ID: 16231053
[TBL] [Abstract][Full Text] [Related]
20. Short-term culture of human CD34+ cells for lentiviral gene transfer.
Santoni de Sio F; Naldini L
Methods Mol Biol; 2009; 506():59-70. PubMed ID: 19110619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
